728x90

기사입력2020.04.06. 오전 7:10

최종수정2020.04.06. 오전 7:11

 

(서울=연합뉴스) 한성간 기자 = 미국 식품의약청(FDA)의 승인을 받아 안전성이 입증된 구충제 이버멕틴(Ivermectin)이 신종 코로나바이러스 감염증(코로나19) 바이러스를 48시간 이내에 죽인다는 세포배양 실험 결과가 나왔다.

호주 모니쉬(Monash)대학 생의학발견연구소(Biomedicine Discovery Institute)의 카일리 왜그스태프 박사는 세포 배양된 코로나19 바이러스가 이버멕틴에 노출되자 48시간 안에 모든 유전물질이 소멸됐다는 실험 결과를 발표했다고 사이언스 데일리가 4일 보도했다.

단 한 번 투여된 용량에도 24시간 후 코로나19 바이러스의 RNA가 상당 부분 줄어들었으며 48시간이 지나자 RNA 전부가 완전히 사라졌다고 왜그스태프 박사는 밝혔다.

그러나 이는 세포 배양 실험에서 나온 결과이기 때문에 코로나19 환자에게 직접 투여하는 임상시험이 필요하다고 그는 설명했다.

이버멕틴은 널리 사용되고 있는 안전한 약이지만 어느 정도 용량을 투여해야 코로나19 감염 환자에게 효과가 있는지를 우선 확인할 필요가 있다고 그는 강조했다.

이버멕틴이 코로나19 바이러스에 작용하는 기전은 알 수 없으나 다른 바이러스에 작용하는 메커니즘을 보면 바이러스가 숙주 세포의 방어력을 '약화'시키지 못하게 차단한다고 왜그스태프 박사는 밝혔다.

이버멕틴은 구충제로 승인된 약이지만 에이즈, 뎅기열, 독감, 지카 바이러스를 포함, 광범한 종류의 바이러스에도 효과가 있는 것으로 시험관실험에서 나타나고 있다고 그는 덧붙였다.

이 연구 결과는 '항바이러스 연구'(Antiviral Research) 최신호에 발표됐다.

원본보기

구충제 이버멕틴[게티이미지뱅크 제공]

728x90

Published:March 16, 2020DOI:https://doi.org/10.1016/S0140-6736(20)30628-0

 

 

As of March 12, 2020, coronavirus disease 2019 (COVID-19) has been confirmed in 125 048 people worldwide, carrying a mortality of approximately 3·7%,

1

 compared with a mortality rate of less than 1% from influenza. There is an urgent need for effective treatment. Current focus has been on the development of novel therapeutics, including antivirals and vaccines. Accumulating evidence suggests that a subgroup of patients with severe COVID-19 might have a cytokine storm syndrome. We recommend identification and treatment of hyperinflammation using existing, approved therapies with proven safety profiles to address the immediate need to reduce the rising mortality.

Current management of COVID-19 is supportive, and respiratory failure from acute respiratory distress syndrome (ARDS) is the leading cause of mortality.

2

 Secondary haemophagocytic lymphohistiocytosis (sHLH) is an under-recognised, hyperinflammatory syndrome characterised by a fulminant and fatal hypercytokinaemia with multiorgan failure. In adults, sHLH is most commonly triggered by viral infections

3

 and occurs in 3·7–4·3% of sepsis cases.

4

 Cardinal features of sHLH include unremitting fever, cytopenias, and hyperferritinaemia; pulmonary involvement (including ARDS) occurs in approximately 50% of patients.

5

 A cytokine profile resembling sHLH is associated with COVID-19 disease severity, characterised by increased interleukin (IL)-2, IL-7, granulocyte-colony stimulating factor, interferon-γ inducible protein 10, monocyte chemoattractant protein 1, macrophage inflammatory protein 1-α, and tumour necrosis factor-α.

6

 Predictors of fatality from a recent retrospective, multicentre study of 150 confirmed COVID-19 cases in Wuhan, China, included elevated ferritin (mean 1297·6 ng/ml in non-survivors vs 614·0 ng/ml in survivors; p<0·001) and IL-6 (p<0·0001),

2

 suggesting that mortality might be due to virally driven hyperinflammation.

As during previous pandemics (severe acute respiratory syndrome and Middle East respiratory syndrome), corticosteroids are not routinely recommended and might exacerbate COVID-19-associated lung injury.

7

 However, in hyperinflammation, immunosuppression is likely to be beneficial. Re-analysis of data from a phase 3 randomised controlled trial of IL-1 blockade (anakinra) in sepsis, showed significant survival benefit in patients with hyperinflammation, without increased adverse events.

8

 A multicentre, randomised controlled trial of tocilizumab (IL-6 receptor blockade, licensed for cytokine release syndrome), has been approved in patients with COVID-19 pneumonia and elevated IL-6 in China (ChiCTR2000029765).

9

 Janus kinase (JAK) inhibition could affect both inflammation and cellular viral entry in COVID-19.

10

All patients with severe COVID-19 should be screened for hyperinflammation using laboratory trends (eg, increasing ferritin, decreasing platelet counts, or erythrocyte sedimentation rate) and the HScore

11

 (table) to identify the subgroup of patients for whom immunosuppression could improve mortality. Therapeutic options include steroids, intravenous immunoglobulin, selective cytokine blockade (eg, anakinra or tocilizumab) and JAK inhibition.

TableHScore for secondary HLH, by clinical parameter

Number of points

Temperature
<38·4°C 0
38·4–39·4°C 33
>39·4°C 49
Organomegaly
None 0
Hepatomegaly or splenomegaly 23
Hepatomegaly and splenomegaly 38
Number of cytopenias

*

One lineage 0
Two lineages 24
Three lineages 34
Triglycerides (mmol/L)
<1·5 mmol/L 0
1·5–4·0 mmol/L 44
>4·0 mmol/L 64
Fibrinogen (g/L)
>2·5 g/L 0
≤2·5 g/L 30
Ferritin ng/ml
<2000 ng/ml 0
2000–6000 ng/ml 35
>6000 ng/ml 50
Serum aspartate aminotransferase
<30 IU/L 0
≥30 IU/L 19
Haemophagocytosis on bone marrow aspirate
No 0
Yes 35
Known immunosuppression

No 0
Yes 18

The Hscore

11

 generates a probability for the presence of secondary HLH. HScores greater than 169 are 93% sensitive and 86% specific for HLH. Note that bone marrow haemophagocytosis is not mandatory for a diagnosis of HLH. HScores can be calculated using an online HScore calculator.

11

 HLH=haemophagocytic lymphohistiocytosis.

* Defined as either haemoglobin concentration of 9·2 g/dL or less (≤5·71 mmol/L), a white blood cell count of 5000 white blood cells per mm3 or less, or platelet count of 110 000 platelets per mm3 or less, or all of these criteria combined.

 HIV positive or receiving longterm immunosuppressive therapy (ie, glucocorticoids, cyclosporine, azathioprine).

PM is a clinical training fellow within the Experimental Medicine Initiative to Explore New Therapies network and receives project funding unrelated to this Correspondence. PM also receives co-funding by the National Institute for Health Research (NIHR) University College London Hospitals Biomedical Research Centre. DFM chairs the NIHR and Medical Research Council funding committee for COVID-19 for therapeutics and vaccines. DFM reports personal fees from consultancy for ARDS for GlaxoSmithKline, Boehringer Ingelheim, and Bayer; in addition, his institution has received funds from grants from the UK NIHR, Wellcome Trust, Innovate UK, and others, all unrelated to this Correspondence. DFM also has a patent issued to his institution for a treatment for ARDS. DFM is a Director of Research for the Intensive Care Society and NIHR Efficacy and Mechanism Evaluation Programme Director. All other authors declare no competing interests.

References

  1. 1.
    • WHO

    Coronavirus disease 2019 (COVID-19)situation report – 52.

    https://www.who.int/docs/default-source/coronaviruse/20200312-sitrep-52-covid-19.pdf?sfvrsn=e2bfc9c0_2

    Date: March 12, 2020

    Date accessed: March 13, 2020

    View in Article

  2. 2.
    • Ruan Q 
    • Yang K 
    • Wang W 
    • Jiang L 
    • Song J

    Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China.

    Intensive Care Med. 2020; (published online March 3.)

    DOI:10.1007/s00134-020-05991-x

    View in Article

  3. 3.
    • Ramos-Casals M 
    • Brito-Zeron P 
    • Lopez-Guillermo A 
    • Khamashta MA 
    • Bosch X

    Adult haemophagocytic syndrome.

    Lancet. 2014; 383: 1503-1516

    View in Article

  4. 4.
    • Karakike E 
    • Giamarellos-Bourboulis EJ

    Macrophage activation-like syndrome: a distinct entity leading to early death in sepsis.

    Front Immunol. 2019; 10: 55

    View in Article

  5. 5.
    • Seguin A 
    • Galicier L 
    • Boutboul D 
    • Lemiale V 
    • Azoulay E

    Pulmonary involvement in patients with hemophagocytic lymphohistiocytosis.

    Chest. 2016; 149: 1294-1301

    View in Article

  6. 6.
    • Huang C 
    • Wang Y 
    • Li X 
    • et al.

    Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.

    Lancet. 2020; 395: 497-506

    View in Article

  7. 7.
    • Russell CD 
    • Millar JE 
    • Baillie JK

    Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury.

    Lancet. 2020; 395: 473-475

    View in Article

  8. 8.
    • Shakoory B 
    • Carcillo JA 
    • Chatham WW 
    • et al.

    Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase iii trial.

    Crit Care Med. 2016; 44: 275-281

    View in Article

  9. 9.
    • Chinese Clinical Trial Registry

    A multicenter, randomized controlled trial for the efficacy and safety of tocilizumab in the treatment of new coronavirus pneumonia (COVID-19).

    http://www.chictr.org.cn/showprojen.aspx?proj=49409

    Date: Feb 13, 2020

    Date accessed: March 6, 2020

    View in Article

  10. 10.
    • Richardson P 
    • Griffin I 
    • Tucker C 
    • et al.

    Baricitinib as potential treatment for 2019-nCoV acute respiratory disease.

    Lancet. 2020; 395: e30-e31

    View in Article

  11. 11.
    • Fardet L 
    • Galicier L 
    • Lambotte O 
    • et al.

    Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome.

    Arthritis Rheumatol. 2014; 66: 2613-2620

    View in Article

Article Info

Publication History

Published: March 16, 2020

Identification

DOI: https://doi.org/10.1016/S0140-6736(20)30628-0

Copyright

© 2020 Elsevier Ltd. All rights reserved.

ScienceDirect

Access this article on ScienceDirect

Tables

 

Related Hub

COVID-19 Resource Centre
Access the latest 2019 novel coronavirus disease (COVID-19) content from across The Lancet journals as it is published.

728x90

Andre Ye

Follow

Mar 16 · 7 min read

 

Something that many people don’t think much about viruses is that, like every other organism on Earth struggling for survival, they evolve, or mutate.

Just look at a snippet of the bat virus RNA nucleotide sequence the human virus was derived from…

AAAATCAAAGCTTGTGTTGAAGAAGTTACAACAACTCTGGAAGAAACTAAGTT

…and a snippet from the human COVID-19’s RNA nucleotide sequence…

AAAATTAAGGCTTGCATTGATGAGGTTACCACAACACTGGAAGAAACTAAGTT

…clearly, the coronavirus has changed its internal structure to adapt to the new species of their host (to be more precise, about 20% of the internal structure of the coronavirus was mutated), but maintained enough such that it is still true to its origin species.

In fact, research has shown COVID-19 has mutated repeatedly in ways to boost its survival. In our fight to defeat the coronavirus, we need to find not just how the virus can be destroyed, but how the virus mutates and how those mutations can be addressed.

In this article, I will…

  • Provide a surface-level explanation of what RNA nucleotide sequences are
  • Use K-Means to create genome information clusters
  • Use PCA to visualize the clusters

…and derive insights from each of the analytics procedures we perform.


What are genome sequences?

Feel free to skip over this part if you have a basic understanding of RNA nucleotide sequences.

Genome sequencing, commonly compared to “decoding,” is the process of analyzing deoxyribonucleic acid (DNA) taken from a sample. Within every normal cell are 23 pairs of chromosomes, structures that house DNA.

Source. Image free to share and use commercially.

The curled double helix structure of DNA allows it to unwind into a ladder shape. This ladder is made out of paired chemical letters called bases. There are only four of these present in DNA: adenine, thymine, guanine, and cytosine. Adenine joins only with thymine, and guanine joins only with cytosine. These bases are represented with A, T, G, and C, respectively.

These bases form a code of sorts that instructs the organism how to construct proteins — it is the DNA that essentially controls how the virus acts.

The process of DNA into RNA into protein creation. Source. Image free to share and use commercially.

Using specialized equipment, including sequencing instruments and specialized tags, the DNA sequences of specific fragments are revealed. Information obtained from this undergoes further analysis and comparison to allow researchers to identify changes in genes, associations with diseases and phenotypes, and identify potential drug targets.

The genome sequence, a long string of ‘A’s, ‘T’s, ‘G’s, and ‘C’s, represents how the organism reacts to its environment. Mutations to an organism are created by altering the DNA. Looking at the genome sequence is a strong way to analyze coronavirus mutations.


Get to know the data.

The data, which can be found on Kaggle here, looks like this:

Each one of the rows represents one mutation of the bat virus. First, just take a minute to admire how incredible nature is — within a few weeks, the coronavirus has already created 262 mutations of itself to increase survival rates.

Some important columns:

  • query acc.ver represents the original virus identifier.
  • subject acc.ver is the identifier for a virus mutation.
  • % identity represents what percent of the sequence is the same as the original virus.
  • alignment length represents how many items in the sequence are the same, or aligned.
  • mismatches represents the number of items that the mutation and the original differ on.
  • bit score represents a measure to represent how good an alignment is; the higher the score, the better the alignment.

Some statistical measures of each of the columns (this can be handily called in Python with data.describe()):

Looking at the % identity column, it is interesting to see the minimum alignment percent a mutation has with the original virus — about 77.6 percent. The rather large standard deviation of 7 percent for % identity means that there is a wide range of mutation. This is supported by a massive standard deviation in bit score — the standard deviation is larger than the mean!

A good way to visualize data is through a correlation heatmap. Each cell represents how correlated one feature is with another.

A lot of the data is highly correlated with each other. This makes sense since most of the measures are variations of each other. One thing to take note of if alignment length’s high correlation with bit score.


Using K-Means to Create Mutation Clusters

K-Means is an algorithm for clustering, a method in machine learning to find groups of data points in the feature space. The goal of our K-Means is to find clusters of mutations, so we can derive insights on the nature of the mutations and how to address them.

However, we still need to choose the number of clusters k. While this is as simple as plotting out the points in two dimensions, this is unachievable in higher dimensions (if we want to retain the most information). Methods like the elbow method to choose k are subjective and inaccurate, so instead, we will use the silhouette method.

The silhouette method is a score given to k clusters on how well the clusters suit the data. The sklearn library in Python makes implementing both K-Means and the silouhette method very simple.

It seems that 5 clusters seems to be the best for the data. Now, we can determine the cluster centers. These are the points in which each cluster is centered around, and represent a numerical evaluation of (in this case) the 5 main types of mutations.

Note: The features have been standardized to put them all on the same scale. Otherwise, columns would not be comparable.

This heatmap represents each cluster’s attributes, by column. Because the points were scaled, the actual annotated values do not quantitatively mean anything. However, scaled values in each column can be compared. You can get a visual sense for the relative attributes of each of the mutation clusters is. If scientists were to develop a vaccine, it should address these main clusters of virii.

In the next section, we will visualize the clusters using PCA.


PCA for Cluster Visualization

PCA, or Principal Component Analysis, is a method of dimensionality reduction. It selects orthogonal vectors in multidimensional space to represent axes, such that the most information (variance) is retained.

With popular Python library sklearn, implementing PCA can be done in two lines. First, we can check the explained variance ratio. This is the percent of statistical information that is retained from the original dataset. The explained variance ratio, in this case, is 0.9838548580740327, which is astronomically high! We can be assured that whatever analyses we take from PCA will be true to the data.

Each new feature (principal component) is a linear combination of several other columns. We can visualize how important a column is to one of the two principal components with a heatmap.

It is important to understand what having a high value in the first component means — in this case, it is characterized by having a higher alignment length (is closer to the original virus), and component 2 is largely characterized by having a shorter alignment length (mutated farther from the original value). This is also reflected by the larger difference in bit score.

It is clear that there are 5 main strands of the virus mutation. We can take away lots of insights.

Four of the virus mutations are on the left side of the first principal component, and one on the right side. A signature of the first principal component is a high alignment length. This means that a higher value for a first principal component means a higher alignment length (is closer to the original virus). Lower values of component 1, thus, are farther genetically from the original virus. Most of the virus clusters vary largely from the original virus. Hence, scientists attempting to create a vaccine should be aware that the virus mutates a lot.


Conclusion

Using K-Means and PCA, were able to identify five main clusters of mutations in the coronavirus. Scientists developing vaccines for the coronavirus can use the cluster centers to gain knowledge about characteristics of each cluster. We were able to visualize the clusters in two dimensions using principal component analysis, and found that the coronavirus has a very high rate of mutation. This may be what makes it so deadly.

Thanks for reading!

If you enjoyed, feel free to check out some of my other work, like this one on taking data into your own hands and unveiling insights on the coronavirus using simple analytics.


Note from the editors: Towards Data Science is a Medium publication primarily based on the study of data science and machine learning. We are not health professionals or epidemiologists, and the opinions of this article should not be interpreted as professional advice. To learn more about the coronavirus pandemic, you can click here.

728x90

송고시간2020-03-18 11:11

 

말레이시아서 첫 사망자 발생…18일부터 31일까지 국가 봉쇄

(자카르타=연합뉴스) 성혜미 특파원 = 신종 코로나바이러스 감염증(코로나19) 확진자가 날씨가 덥고 습한 인도네시아, 말레이시아 등 동남아시아에서도 계속 늘고 있다.

18일 현지 매체에 따르면 인도네시아의 코로나19 확진자는 172명, 말레이시아는 673명으로 각각 늘었다.

싱가포르는 243명, 필리핀 187명, 태국 177명, 베트남 61명, 브루나이 54명 등이다.

말레이시아-싱가포르 국경

[AFP=연합뉴스]

동남아에서 확진자가 가장 많은 말레이시아 경우 이달 9일까지만 해도 99명으로 두 자릿수였지만, 2월 28일∼3월 1일 쿠알라룸푸르 스리 페탈링 이슬람사원에서 1만6천여명이 참석한 종교 행사에서 집단 감염이 발생했다.

 

말레이시아 확진자 673명 가운데 3분의 2를 비롯해 브루나이 50명, 싱가포르 5명, 캄보디아 13명, 태국 최소 2명이 이 행사를 통해 직·간접적으로 감염됐다.

말레이시아에서는 이 행사에 참석했던 34세 남성이 코로나19에 감염된 뒤 첫 사망자로 기록됐다.

보르네오섬 말레이시아령 사라왁주의 60세 남성도 코로나19 감염 후 사망자로 발표됐다.

말레이시아 '국가봉쇄' 전날 사재기 기승

[AP=연합뉴스]

인도네시아는 지난달까지만 해도 코로나19 확진자 0명을 기록해 '검진 능력이 떨어진다', '은폐하는 것이 아니냐' 등의 의혹이 제기됐으나 이달 2일 첫 확진자 발생 후 현재 감염자가 172명까지 늘었다.

일각에서는 '고온다습한 기후가 신종코로나 바이러스의 활동을 억제할 것'이라며 날씨가 더워지면 코로나19 사태가 잦아들 것으로 기대하지만, 최근 동남아시아의 확진자 증가 속도로 볼 때 근거가 있다고 보기 힘들다.

세계보건기구(WHO)는 최근 홈페이지에 올린 글을 통해 "지금까지의 증거로 미뤄 신종 코로나바이러스는 무덥고 습한 지역을 포함한 모든 지역에서 전염될 수 있다"고 밝혔다.

18일 오전 자카르타 날씨 '고온 다습'

[구글 캡처]

동남아시아 국가들은 최근 잇따라 '국가 봉쇄' 등 강력한 예방조치를 내놓고 있다.

로드리고 두테르테 필리핀 대통령은 17일 전국에 비상사태를 선포하고 코로나19 확산 예방을 위한 총동원령을 내렸다.

무히딘 야신 말레이시아 총리도 이날부터 31일까지 2주 동안 모든 외국인의 입국 금지와 자국민 해외여행 금지 등 이동제한 조처를 내렸다.

말레이시아는 종교, 스포츠, 문화 활동을 포함한 단체 활동이나 모임을 전국적으로 금지했고, 필수서비스를 제외한 정부 기관과 개인 소유 사업장을 모두 폐쇄했다.

식당은 테이크아웃과 배달만 허용되고, 호텔들은 새로운 투숙객을 받지 않는다.

말레이시아 내에서 다른 주로 이동하는 것도 특별한 경우에만 허용된다.

인도네시아 수라바야의 모스크 방역

[로이터=연합뉴스]

인도네시아는 20일 0시부터 한국을 포함해 모든 외국인에 대한 무비자 입국과 도착 비자 발급을 전면 중단한다.

인도네시아에 입국하려는 외국인은 건강확인서를 재외 인도네시아 공관에 제출하고, 사전에 비자를 발급받아야 한다.

인도네시아 국가재난방지청(BNPB)은 2월 29일에 내린 코로나19 관련 비상사태를 5월 29일까지 연장했다.

인도네시아의 인구가 2억7천만명에 이르기에 조코 위도도 대통령에게 '도시 봉쇄' 등 코로나19 확산을 막기 위한 더 적극적인 조치를 하라는 목소리가 커지고 있다.

noanoa@yna.co.kr

<저작권자(c) 연합뉴스, 무단 전재-재배포 금지>2020/03/18 11:11 송고

+ Recent posts